Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This board is for mj plays only. Please stay on-topic.
Connection to marijuana?
yah mon 420 updates daily, many more to post, stay tuned, and please let us know which ones are missing from lists.. GL&HF! B~)
What does GOVX have to do with marijuana?
Hey buddeh, your indicators might be getting removed due to the way you edit your chart permalink... here's an example from Stockcharts.com: the original link being "http://stockcharts.com/h-sc/ui?s=JAMN&p=D&yr=0&mn=6&dy=0&id=p68003465796", what I do is edit the line to read "chart]http://stockcharts.com/c-sc/sc?s=JAMN&p=D&yr=0&mn=6&dy=0&id=p68003465796[/chart" and it keeps your indicators intact over time. This is another MJ pincher pattern opening up bigglies right now. GL!
Pot stocks are smoking right now, anyone have a pincher formation pinging in the MJ sector?
Don't see any technical pincher patterns on AMRS, DNRG, or FDBL, unless you go back to 2015 weekly charts, but even back then that's still stretching our definitions. Please clarify your opinions or posts will be removed from board.
MBLX tight pinch divergence occurred August 23rd on daily charts. Weekly ppo/adx pinch divergence following more loosely currently underway charts here: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124745281
Freshly loaded into AGTC as well
MBLX chart caught my eye, anyone buying this one up here? Article out today from Scibilitymedia:
Radical Transformation At Metabolix, Inc. (NASDAQ:MBLX)
Metabolix, Inc. (NASDAQ: MBLX) has set itself on a path to transformation. First, the company has announced that it is selling its biopolymer business to a South Korean food company called CJ CheilJedang Corporation for $10 million. The transaction is expected to close next month, subject to customary closing conditions.
What is Metabolix selling?
Metabolix, Inc. (NASDAQ: MBLX) is particularly selling patents and laboratory equipment of its biopolymer business. The assets being sold include the microbial strain platform that has been used to develop the company’s fermentation-based products.
Metabolix has already received $2 million from CJ in connection with the sale of biopolymer assets. The balance of $8 million will be released up the closing of the transaction in mid-September.
Subleasing contract
Besides buying Metabolix’s biopolymer business, CJ has also entered an agreement to sublease space at Metabolix’s plant in Woburn, Massachusetts. However, the financial terms of the subleasing deal weren’t disclosed.
Transformation of the business
After offloading the biopolymer business, the second thing that Metabolix, Inc. (NASDAQ: MBLX) intends to do as part of its transformation is rebranding. The company plans to change its name to Yield10 Bioscience in the coming months. CEO Joseph Shaulson said that the sale of biopolymer operation will enable them to gain more footing in their core business and hopefully generate more value for shareholders.
The CEO added that the focus of the management team at Metabolix is on developing disruptive technologies that help to improve crop yield.
Lean corporate structure
Metabolix, Inc. (NASDAQ: MBLX)’s transformation will see the company have a lean corporate structure once the pending transactions are completed. For instance, the restructured company will only have about 20 staff and its annual cash burn is expected to drop to the vicinity of $5 million.
Financial results – Metabolix, Inc. (NASDAQ: MBLX)
Metabolix, Inc. (NASDAQ:MBLX) generated revenue of less than $2.6 million in 2015, down 7% from the previous year. It logged a loss of $23.7 million in 2015, which was slightly better than a loss of $29.5 million in the prior year.
Roger that. Sitting directly at 32EMA. Lock and load.
BRIEF-Euroseas reports qtrly loss per share $2.42
REUTERS - 9:08 AM ET
Aug 11 (Reuters) - Euroseas Ltd (ESEA)
* Qtrly loss per share $2.42
* Results of Q2 of 2016 reflect low levels of containership and drybulk markets compared to same quarter of 2015
* Announces that company's board authorized establishment of an ATM offering of up to 15% of company's outstanding shares
* Qtrly net revenues $7.3 million versus $9.4 million
* Euroseas Ltd (ESEA) says has agreed to purchase M/V Aegean Express for approximately $3 million Source text for Eikon: Further company coverage: